Sifting through countless of stocks in the Health Care Providers & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Elevance Health, Inc., The Ensign Group or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.
Read on to learn how Elevance Health, Inc., The Ensign Group and Inc. compare based on key financial metrics to determine which better meets your investment needs.
About Elevance Health, Inc., The Ensign Group and Inc.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and standard services, such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. The Standard Bearer segment leases post-acute care properties to healthcare operators. In addition, the company operates senior living units; and provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. The company operates healthcare facilities in Alabama, Alaska, Arizona, Colorado, Idaho, Iowa, Kansas, Oregon, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Latest Health Care Providers & Services and Elevance Health, Inc., The Ensign Group, Inc. Stock News
As of July 30, 2026, Elevance Health, Inc. had a $81.6 billion market capitalization, compared to the Health Care Providers & Services median of $1.9 million. Elevance Health, Inc.’s stock is up 7.2% in 2026, down 0.5% in the previous five trading days and up 30.36% in the past year.
Currently, Elevance Health, Inc.’s price-earnings ratio is 16.7. Elevance Health, Inc.’s trailing 12-month revenue is $201.1 billion with a 2.5% net profit margin. Year-over-year quarterly sales growth most recently was 1.4%. Analysts expect adjusted earnings to reach $27.158 per share for the current fiscal year. Elevance Health, Inc. currently has a 1.8% dividend yield.
As of July 30, 2026, The Ensign Group, Inc. had a $10.3 billion market cap, putting it in the 78th percentile of all stocks. The Ensign Group, Inc.’s stock is up 2.3% in 2026, up 3% in the previous five trading days and up 18.42% in the past year.
Currently, The Ensign Group, Inc.’s price-earnings ratio is 28.0. The Ensign Group, Inc.’s trailing 12-month revenue is $5.5 billion with a 6.9% net profit margin. Year-over-year quarterly sales growth most recently was 17.3%. Analysts expect adjusted earnings to reach $7.794 per share for the current fiscal year. The Ensign Group, Inc. currently has a 0.1% dividend yield.
How We Compare Elevance Health, Inc., The Ensign Group and Inc. Stock Grades
Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.
AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Elevance Health, Inc., The Ensign Group and Inc.’s stock grades to see how they measure up against one another.
Learn more about A+ Investor here!
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
Elevance Health, Inc., The Ensign Group and Inc. Growth Grades
| Company | Ticker | Growth |
| Elevance Health, Inc. | ELV | A |
| The Ensign Group, Inc. | ENSG | A |
The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.
In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.
The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.
Elevance Health, Inc. has a Growth Score of 100, which is Very Strong.
The Ensign Group, Inc. has a Growth Score of 89, which is Very Strong.
The Growth Grade Winner: It’s a Tie!
Looking at the Growth Grade breakdown above, both Elevance Health, Inc., The Ensign Group and Inc. have a grade of A. For investors who focus solely on a company’s upward growth, further research should be conducted into both companies’ other financial metrics before deciding whether to invest.
Elevance Health, Inc., The Ensign Group and Inc.’s Quality Grades
| Company | Ticker | Quality |
| Elevance Health, Inc. | ELV | A |
| The Ensign Group, Inc. | ENSG | B |
Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.
The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.
The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.
Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.
Elevance Health, Inc. has a Quality Score of 83, which is Very Strong.
The Ensign Group, Inc. has a Quality Score of 61, which is Strong.
The Quality Grade Winner: Elevance Health, Inc.
As you can clearly see from the Quality Grade breakdown above, Elevance Health, Inc. has a better overall quality grade than The Ensign Group, Inc.. For investors who are looking for companies with higher quality than others in the same industry, Elevance Health, Inc. could be a good stock to add to their portfolios. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.
Elevance Health, Inc., The Ensign Group and Inc.’s Momentum Grades
| Company | Ticker | Momentum |
| Elevance Health, Inc. | ELV | C |
| The Ensign Group, Inc. | ENSG | C |
Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.
Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.
Elevance Health, Inc. has a Momentum Score of 56, which is Average.
The Ensign Group, Inc. has a Momentum Score of 49, which is Average.
The Momentum Stock Winner: No Clear Winner
Neither Elevance Health, Inc., The Ensign Group or Inc. has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Elevance Health, Inc., The Ensign Group or Inc. is the better investment when it comes to momentum.
Don’t Forget Your Free Special Report on How A+ Grades Can Help You Make Investment Decisions
Other Elevance Health, Inc., The Ensign Group and Inc. Grades
In addition to Momentum, Growth and Quality, A+ Investor also provides grades for Value and Estimate Revisions.
Earnings estimate revisions scores take into account the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, surprises beget further surprises‐or at least continued sales growth (the exact opposite is generally true, too).
Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.
These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Elevance Health, Inc., The Ensign Group and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.
So, Which Is the Better Investment, Elevance Health, Inc., The Ensign Group or Inc. Stock?
Overall, Elevance Health, Inc. stock has a Growth Score of 100, Momentum Score of 56 and Quality Score of 83.
The Ensign Group, Inc. stock has a Growth Score of 89, Momentum Score of 49 and Quality Score of 61.
Comparing Elevance Health, Inc., The Ensign Group and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.
Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.
A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.
AAII Disclaimer
We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.
Included With AAII Platinum
at only 23.3%
Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.